Patients with diabetes were treated with metformin (MTF) and/or inhibitors of dipeptidyl peptidase 4 (DPP4i) and/or sodium-glucose cotransporter-2 inhibitors (SGLT2i); no treatment had been given on the day of admission. The gene discussed is DPP4; the disease is diabetes mellitus.